Business Context and Reporting Period
Company: Alterity Therapeutics Limited
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: August 2019
Principal Executive Office: Level 3, 460 Bourke Street, Melbourne, VIC 3000, Australia
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This Form 6-K serves as a cover document incorporating an external report (Appendix 3B) by reference and does not contain embedded financial tables or narrative data.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. No comparative financial data or operational updates are included in the provided text.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to administrative details and the incorporation of Appendix 3B by reference.
Key Facts for Investor Verification
- The registrant files annual reports under Form 20-F.
- This Form 6-K incorporates Appendix 3B by reference; investors must locate and review Appendix 3B for substantive information.
- The report is incorporated by reference into Registration Statements on Form F-3 (File No. 333-220886) and Form S-8 (File No. 333-228671).
- The report was signed by Geoffrey Kempler, Executive Chairman, on August 1, 2019.